Hologic (NASDAQ: HOLX) reported Q4 EPS of $0.38, $0.01 better than the analyst estimate of $0.37. Revenue for the quarter came in at $660.6 million versus the consensus estimate of $636.2 million.

Hologic sees FY2015 EPS of $1.50-$1.54, versus the consensus of $1.56. Hologic sees FY2015 revenue of $2.54-2.57 billion, versus the consensus of $2.58 billion.

Hologic sees Q1 2015 EPS of $0.35-$0.36, versus the consensus of $0.37. Hologic sees Q1 2015 revenue of $625-635 million, versus the consensus of $636.13 million.

"Our fourth quarter provides further evidence that our turnaround is strengthening and our outlook is improving," said Stephen MacMillan, President and Chief Executive Officer. "Although we began the year with declining performance, this quarter we achieved growth in all four franchises and transitioned to a company on a clear path to sustainable organic growth. While we still have work to do, we have put the pieces in place to drive accelerating growth and are much better positioned as we head into fiscal 2015."

For earnings history and earnings-related data on Hologic (HOLX) click here.